Skip to main content
Equibles

Invesco Ltd.

Position in TGTX — Tg Therapeutics, Inc.

CIK 914208 Atlanta, GA
Back to TGTX Full portfolio

Position in TGTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$22,352,831
-$1,596,594 QoQ
Shares Held
406,859
-43.6% QoQ
Ownership
0.266%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 426 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 0% Shared 91% None 9%

Common Shares in TGTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. TGTX ranks #41 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 8,043,052 $3,995,225,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,940,665 $2,457,162,245
3 ALNY
Alnylam Pharmaceuticals, Inc.
 3,754,318 $1,130,162,341
4 INCY
Incyte Corp
 4,080,461 $462,561,050
5 ARGX
Argenx SE
 443,990 $411,920,598
6 AXSM
Axsome Therapeutics, Inc.
 1,671,684 $409,178,086
7 MRNA
Moderna, Inc.
 5,780,299 $404,794,337
8 LGND
Ligand Pharmaceuticals Inc
 1,201,644 $379,827,645

All Filings in TGTX

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $22,352,831 406,859
2026-03-31 $23,949,425 720,934
2025-12-31 $47,988,583 1,609,815
2025-09-30 $39,532,814 1,094,334
2025-06-30 $34,906,876 969,905
2025-03-31 $47,743,499 1,210,842
2024-12-31 $27,985,262 929,743
2024-09-30 $21,489,654 918,754
2024-06-30 $8,366,920 470,316
2024-03-31 $8,572,949 563,639
2023-12-31 $12,122,477 709,747
2023-09-30 $2,882,718 344,823
2023-06-30 $7,653,203 308,100
2023-03-31 $3,715,134 247,017
2022-12-31 $3,252,219 274,913
2022-09-30 $641,229 108,316
2022-06-30 $1,469,364 345,733
2022-03-31 $3,142,671 330,460
2021-12-31 $31,393,301 1,652,279
2021-09-30 $59,850,515 1,798,393
2021-06-30 $43,494,953 1,121,293
2021-03-31 $53,063,137 1,100,895
2020-12-31 $92,662,808 1,781,292
2020-09-30 $28,380,424 1,060,554